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Abstract: Background: Rehabilitation programs are comprehensive interventions which effectively improve the health 
status and reduce costs in chronic respiratory illnesses. Because patients with cystic fibrosis have been discouraged to 
participate for concerns of microbial cross infection, the efficacy of systematic rehabilitation is unknown for this group. 
Methods: We retrospectively studied 142 cystic fibrosis patients aged 2-46 years who participated in rehabilitation 
programs taking place in Germany/Switzerland and in Israel, focusing on changes in lung function and weight. 
Results: During 172 stays in 97 patients in Israel and 68 stays in 45 patients rehabilitating in Germany/Switzerland, 
overall lung function and weight improved. Outcome did not differ between Israel and German/Swiss sites. Interestingly, 
lung function improved during the initial phase of the stay, whereas weight gain was sustained throughout. The study 
uncovered gaps in reporting sufficient individual outcome information back to the admitting centre. 
Conclusions: Rehabilitation programs specified for cystic fibrosis patients need to be assessed prospectively to optimize 
treatment of this life limiting condition. 
Keywords: Cystic fibrosis, rehabilitation, summer camp. 
INTRODUCTION 
  A recent statement of the American Thoracic Society 
(ATS) and the European Respiratory Society (ERS) on 
pulmonary rehabilitation highlights the great progress that 
has been made in evidence-based support for pulmonary 
rehabilitation in the management of patients with chronic 
respiratory disease [1]. Rehabilitation programs are 
comprehensive interventions which have been shown 
primarily for individuals with chronic obstructive pulmonary 
disease (COPD), to reduce dyspnoea, increase exercise 
performance, improve health-related quality of life (HRQL), 
and to reduce effectively health care costs [1]. 
  Although it has become clear that patients regardless of 
the type of chronic respiratory disease, experience a 
substantial morbidity from secondary impairments, like 
peripheral muscle, cardiac, nutritional, and psychosocial 
dysfunction, as well as suboptimal self-management 
strategies, comparable data are barely available in patients 
with cystic fibrosis. In fact, in the mentioned ATS/ERS 
statement this disease entity is mentioned only twice [1]. 
Thus it is evident that for cystic fibrosis patients up-to-date  
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evaluated and structured rehabilitations programs have not 
yet been developed. Reasons for this may include that cystic 
fibrosis patients only represent a small group of subjects, 
include a broad age range from infancy to adulthood, and 
most importantly the bad experiences made previously in so-
called summer camps. These were holiday-like rehabilitation 
efforts for cystic fibrosis patients, which were not infection 
controlled and cohorted considering pulmonary pathogens. 
In these camps a significant risk of microbial cross infection 
between patients was demonstrated [2-8]. Nevertheless, 
rehabilitation programs in cystic fibrosis have a long 
standing tradition in some European countries [9-13]. These 
programs absolutely differ from the so-called summer 
camps, especially because of taking very carefully into 
account hygiene aspects, among many other factors. They 
are perceived as helpful from a patient’s perspective, as they 
appear to improve health status, specific physiotherapeutic 
and psychosocial skills, and disburden families with small 
children and single adults. Many physicians share this 
attitude; the programs are paid by the national state insurance 
system every 4 years, in exceptional cases depending on 
individual state of health every 1-2 years. 
  Unfortunately very little is known on the quality and 
safety of these programs. For a full positioning of such 
programs and more importantly for their future development 
into definite evidence based pulmonary rehabilitation for CF 
patients according to state of the art knowledge, a description 
of the current outcome of these programs is desirable. 2    The Open Respiratory Medicine Journal, 2010, Volume 4  Griese et al. 
  We therefore evaluated the effect of rehabilitation 
programs at different sites and in an unbiased manner by 
comparing data on the clinically most important 
measurements concerning lung function and bodyweight 
before and after the programs. Additionally, the amount of 
missing data from rehabilitation site reports was analysed. 
MATERIALS AND METHODOLOGY 
  We retrospectively studied the rehabilitation related data 
from all consecutive subjects at our center processed by one 
single social worker who had participated in the rehabili-
tation program in Israel during the seasons 1999/2000 to 
2003/2004 and the data from all subjects who participated in 
German/Swiss rehabilitation programs during a similar time 
period. The patients from the German/Swiss rehabilitation 
centres were combined to one group, in order to compare the 
results to the Israel rehabilitation program which took place 
in a totally different climate during winter time in Germany 
and Switzerland. 
Medical Sites 
The Israel Rehabilitation Site 
  The program is located at the Christiane-Herzog-Dead 
Sea Cystic Fibrosis-Climate Therapy Centre, located in the 
rehabilitation hotel Lot, Ein Bokek, Israel. The site is located 
390 m below sea level, with humidity of 20-50 %, a lack of 
pollen, and temperatures between maximal 20-23°C and 
minimal 11-14°C. The program was active during the winter 
season of Germany and Switzerland and the length of the 
stay for each patient was 3 weeks. 
The German/Swiss Rehabilitation Sites 
  The six German speaking rehabilitation sites were the 
Alpine Kinderklinik Davos, Davos, Switzerland; Klinikum 
Berchtesgadener Land, Berchtesgaden, Germany; Rehabili-
tationszentrum Borkum-Klinik Borkum Riff, Borkum, 
Germany; Fachklinik Satteldüne, Amrum, Germany; Kinder-
Rehazentrum Usedom, Usedom, Germany; Nachsorgeklinik 
Tannheim, Villingen-Schwennigen-Tannheim im Schwarz-
wald, Germany. 
  The program was active mainly during the spring to 
autumn season of Germany and Switzerland, 73% of the 
stays were during the warm season (May to August), and the 
length of the stay for each patient was 3 weeks or longer. 
Main Features of the Rehabilitation Programs 
  The rehabilitation programs included daily chest 
physiotherapy for one hour in addition to routine self-
physiotherapy. The maintenance therapy with oral and/or 
inhaled antibiotics, pancreatic enzyme supplements, vitamins, 
and bronchodilator inhalations as individually prescribed by 
each patient’s physician, was kept constant. A number of 
structured outdoor physical activities including various ball 
games, horse riding, cycling and walking tours, yoga and other 
self-stabilizing techniques, and social activities were offered for 
participation. A high caloric food with daily nutritional 
supplements was reinforced in all subjects. Details on the 
instrumentation of the different sites are given in Table 1. 
  All patients were defined according to their 
microbiological status and grouped into those without 
Pseudomonas  aeruginosa ( P. aeruginosa) and with P. 
aeruginosa. Patients with B. cepacia o r  M R S A  w e r e    
excluded from the regular program. The categorization of the 
patients was done on the basis of sputum or throat swab 
examinations from the year before the stay. At least three 
previous 3 monthly results had to be available and, in 
addition, a recent swab from within the last 2 months before 
the stay. Furthermore, all patients were educated in personal 
hygiene measures along the guidelines for infection control 
in outpatient cystic fibrosis patients as published previously 
[14] including disinfection of hands, no close contact to 
other participants, and strict usage of personal equipment for 
inhalation. At all sites the appropriate hygiene surface and 
cleaning procedures were in place. In all programs the 
patients usually had private rooms; in case of small children 
these were shared with a family member accompanying 
them. Patients usually brought their own personal inhalation 
devices, sterilizing equipment for these, and their medication 
with them. 
Patient Population, Outcome Variables and Comparisons 
  Inclusion criteria were the diagnosis of cystic fibrosis by 
clinical symptoms and a positive sweat test or conclusive 
molecular genetics and a clinically stable condition. Indications 
for the medical rehabilitation were of broad nature, though 
including in all patients an unsatisfying course of weight and/or 
lung function or dissatisfactory compliance with therapy. 
Details on the numbers and the baseline characteristics of the 
patients participating are given in Tables 2 and 3. 
  The patients were seen at the rehabilitation centre by a 
medical doctor and clinical data as bodyweight, height, 
spirometry, and transcutaneous oxygen saturation were taken 
at the beginning (Table 3) and at the end of the stay ideally. 
In a subset of patients these data were obtained after one 
week, in addition daily peak flow measurements and a 6 min 
walking test on a treadmill was performed at the beginning 
and the end of these stays. In a first step, differences between 
the initial measurements taken at the site and the last 
measurements taken at the site were performed. Therefore 
only complete (before and after) pairs are considered and the 
number N of which is indicated. The changes are indicated 
as median in the units of the original variable (see Table 3) 
and as absolute numbers of subjects. A change was defined 
as “better” if the value taken at the end was higher than at the 
beginning, as “same”, when the vales were the same and as 
“worse”, when the values were lower. Comparisons between 
the before and after changes were made by Wilcoxon test, P 
is indicated (Table 4). 
  In a second step, comparisons between the Israel and the 
German/Swiss programs were performed. For an optimal 
comparison, the subjects were carefully matched for age, 
Pseudomonas state, sex, and baseline values of weight and lung 
function. As the number of subjects was smaller in the 
German/Swiss programs, it was attempted to match these to 
appropriate subjects in the Israel program. For the 68 
rehabilitation stays in the German sites, 5 patients could not be 
matched due to non-documented matching variables and in 
three patients no fitting matching partner could be identified. 
Statistics 
 All variables were treated by non-parametric   
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Table 1.  Rehabilitation Sites and Their Instrumentation 
 
Rehabilitation Site  1  2  3  4  5  6  7 
Physician Related 
Specialist in cystic fibrosis on location  Yes  Yes  Yes  Yes  Yes  Yes  Yes 
Intravenous antibiotic therapy possible  No  Yes  Yes  Yes  Yes  Yes  Yes 
Physiotherapy and Sport 
Workout and tutorials under supervision of a sports therapist Yes  Yes  Yes  Yes  Yes  Yes  Yes 
Physiotherapy lessons and tutorials under supervision of a physiotherapist Yes  Yes  Yes  Yes  Yes  Yes  Yes 
Physiotherapist with accredited CF training  Yes  Yes  Yes  Yes  Yes  Yes  Yes 
Nutrition 
Analysis of dietary records and nutritional counselling by a nutritionist Yes  Yes  Yes  Yes  Yes  Yes  Yes 
Diabetes advisor with CF experience on location  No  Yes  Yes  Yes  No  No  No 
Psychological Related 
Intergroup development and one on one interview with a psychotherapist Yes  Yes  Yes  Yes  Yes  Yes  Yes 
Intergroup development and one on one interview with a social worker No  Yes  Yes  Yes  Yes  Yes  Yes 
Private lessons with a schoolteacher possible  No  Yes  No  No  Yes  Yes  Yes 
Monitoring of appointed measures by healthcare workers Yes  Yes  Yes  Yes  Yes  Yes  Yes 
Other 
Intensive care in case of acute medical problems possible  Yes  Yes  Yes  Yes  Yes  Yes  Yes 
Particular climatic condition  Yes  Yes  Yes  Yes  Yes  Yes  No 
Spatiotemporal segregation according to P. aeruginosa status  Yes  Yes  Yes  Yes  Yes  Yes  Yes 
Infection control measures  Yes  Yes  Yes  Yes  Yes  Yes  Yes 
1  Christiane-Herzog-Dead Sea Cystic Fibrosis-Climate Therapy Centre, Israel. 
2  Alpine Kinderklinik Davos. 
3  Klinikum Berchtesgadener Land. 
4  Klinik Borkum Riff. 
5  Fachklinik Satteldüne, Amrum. 
6 Kinder-Rehazentrum  Usedom. 
7 Nachsorgeklinik  Tannheim. 
 
 
Table 2.  Overview on Rehabilitation Sites, Number of Patients and Duration of Programs 
 
 Seasons/Sites  Number  of 
Stays 
Duration of Stays 
(Days) 
Number of 
Patients 
Number of Patients Coming for the 
First Time to that Site 
1999/2000  52 21 52  52 
2000/2001  55 21 55  35 
2001/2002  23 21 23  4 
2002/2003  14 21 14  4 
2003/2004  28 21 28  2 
Israel 
Sum or mean  172  21  172  97 
Site 2, 1995-1998  6  30.3  5  5 
Site 3, 2000-2004  5  28.8  5  4 
Site 4, 1998-2004  3  25.3  3  2 
Site 5, 1994-2005  17  38  10  10 
Site 6, 1997-2004  28  28  16  14 
Site 7, 1999-2005  9  28  6  4 
Germany, Switzerland 
Sum or mean  68  30.5  45  39 4    The Open Respiratory Medicine Journal, 2010, Volume 4  Griese et al. 
Wilcoxon matched pairs, in case of three, Friedman Test 
followed by Dunn´s post hoc test. Two unpaired groups were 
compared by Mann-Whitney Test, more by Kruskal-Wallis 
ANOVA, followed by Dunn´s post-hoc test. A two-sided p < 
0.05 was considered significant. Summary data are given as 
medians with range or interquartile range. 
Ethics Approval  
  The retrospective chart review of the results from the 
rehabilitation centers was performed anonymised. The use of 
all data obtained was approved by the local institutional 
review board for human studies of the University of Munich. 
RESULTS 
Variable but on Average High Percentage of Missing 
Data in Reports from Rehabilitation Sites 
  From all 142 different subjects and the total number of 
240 different rehabilitation stays noted in our files to have  
been sent to rehabilitation programs, records were retrieved. 
These were systematically analyzed for the pre-defined key 
variables listed in Table 3. Whereas lung function values 
frequently were not reported by the sites in Germany/ 
Switzerland, weight was less frequently reported from the Israel 
site. Values for peak flow and a 6 min walk test were solely 
reported in a small subgroup of patients for certain seasons. 
Improvement of Lung Function and Weight with the 
Rehabilitation Intervention 
  First we analyzed all cystic fibrosis patients staying at the 
Israel site and those at the German and Swiss sites separately. 
Whereas the baseline data for age, lung function, weight and 
Pseudomonas status of the two groups of patients were very 
similar, the number of missing values for some variables was 
different between the groups (Table 3). Overall lung function 
values and weight improved (Table 4). At the Israel site FVC 
and oxygen saturation improved significantly, whereas at the 
German sites FEV1 did. In order to better describe individual 
outcomes, the numbers of patients improving, getting worse or 
remaining unchanged were assessed (Table 4). Whereas a 
substantial fraction of subjects deteriorated with respect to lung 
function, weight clearly improved in the majority of patients, 
both in the German and Israel sites (Table 4). Taken together, 
rehabilitation programs at both sites led to improved lung 
function and weight. 
Early Improvement of Lung Function and Sustained 
Gain of Weight 
  The variable duration of the stays in the German/Swiss 
rehabilitation sites could be used to assess the effect of 
length of stay on the outcome of rehabilitation. In addition, 
this aspect was addressed in 61 patients in the seasons 
2000/2001, 2001/2002, 2002/2003 and 2003/2004 of the 
Israel rehabilitation programs. During these stays additional 
measurements at the end of the first week (on average on day 
9.2) of the 3-week stay were performed. 
  In this subgroup of 61 patients significant changes of 
paired lung function (FEV1, FVC, MEF25-75, oxygen-
saturation), weight and BMI were observed. Whereas lung 
function clearly improved during the first week, weight 
improved continuously over the whole rehabilitation period 
(Fig.  1). This observation is in agreement with the 
observation that the gain of weight, but not the improvement 
of FEV1 was proportional with the duration of the 
rehabilitation programs (Fig. 2). 
Table 3.  Baseline Characteristics of the Cystic Fibrosis Patients Included 
 
  N,  
n* 
Age 
(y) 
Male  
(%) 
P ae.§  
Pos 
(%) 
FEV1 
(% 
pred) 
FVC 
(% 
pred) 
MEF25-75  
(% 
pred) 
Oxygen- 
Saturation  
(%) 
Weight  
(kg) 
BMI 
(kg/m
2) 
PEF 
***  
(l/min) 
6MWT 
**** 
(m) 
Israel  172,  
97 
16.5 
(2-
46) 
48 
 
69  63 
(15-122) 
82 
(15-152) 
31 
(4-135) 
97 
(78-99) 
47 
(13-82) 
18 
(13-27) 
390 
(210-
500) 
400 
(120-590) 
Data missing** 
(%; n/N) 
 0 0  0  24 % 
(42/172) 
24 % 
(42/172) 
24 % 
(42/172) 
17% 
(29/172) 
24 % 
(41/172) 
33 % 
(57/172) 
4 % 
(1/23) 
59 % 
(30/51) 
Germany/  
Switzerland 
68,  
45 
14.0 
(3-
33) 
60 60  63 
(27-110) 
73.6 
(4-106) 
30.5 
(12-49) 
Not  
reported 
41.3 
(14-78) 
Not  
reported 
Not  
reported 
Not  
reported 
Data missing** 
(%; n/N) 
  4 % 
(3/68) 
0  4 % 
(3/68) 
54 % 
(37/68) 
82 % 
(56/68) 
94 % 
(64/68) 
  10 % 
(7/68) 
    
Comparison of 
 missing data from  
sites Israel and  
Germany/Switzerland
# 
  ns    ns  <0.0001 <0.0001 <0.0001  nd  0.018  nd  nd  nd 
FEV1: Forced Expiratory Volume in 1 Second; FVC: forced expiratory vital capacity, MEF25-75: Middle Expiratory Flow between 25% and 75% of FVC, BMI: Body Mass Index, 
PEF: Peak Expiratory Flow rate, 6MWT: 6-minute walk test. 
* N indicates the number of stays included and n the number of subjects. Of the 97 patients included in the Israel program, 38 participated several times (14 patients 2 times, 12 
patients 3 times, 11 patients 4 times and 1 patient 5 times). Of the 45 patients included in the German speaking site program, 12 participated several times (8 patients 2 times, 1 
patient each 3, 4, 5, and 7 times). § P. aeruginosa status at start of a stay. 
** Given is the percentage of measurements expected (no correction is made for lung function measurements in children of young age) and in brackets the number of missing 
information on stays in relation to the total number of stays included. 
*** obtained in season 2001/2002 in total of 23 subjects. **** obtained in seasons 2001/2002, 2003/2004, in total of 51 subjects. 
# Frequencies were compared by Fisher´s exact test. 
Data are median (min-max). Rehabilitation in Cystic Fibrosis  The Open Respiratory Medicine Journal, 2010, Volume 4    5 
No Differences in the Extent of the Rehabilitation Effects 
Between Israel and German/Swiss Sites 
  A direct overall comparison of the Israel and German 
rehabilitation programs did not show significant differences 
of the basal data and of the changes associated with the 
rehabilitation with respect of age, sex, percentage of 
Pseudomonas positive subjects, weight, and lung function. It 
must be noted however that the time of the year when the 
programs took place and their durations were different, as 
were the numbers of participants (Tables 2 and 3). 
  To circumvent some of these problems an additional 
comparison was made after very careful matching of subjects 
for age, Pseudomonas state, sex, and baseline values of 
weight and lung function. Again, no differences for the 
improvement of lung function (Fig. 3a, b) and weight were 
observed (Fig. 3c). The figure illustrates the wide range of 
individual changes observed. 
Table 4.  Differences in Variables Before and After Rehabilitation in All Cystic Fibrosis Patients Included for the Israel, Dead Sea 
Area (172 Stays) and the German and Swiss Sites (68 Stays) 
 
Israel Germany,  Switzerland 
Change in   Absolute  
Difference  P  N of  
Pairs 
N 
Better 
N 
Same 
N 
Worse 
Absolute  
Difference  P  N of  
Pairs 
N 
Better 
N 
Same 
N 
Worse 
FEV1 (% pred)  1.0 (-3, 5)  0.10  130  71  12  47  3.0 (-0.5, 9.5)  0.035  30 22  2  6 
FVC (% pred)  4.0 (-2, 11)  <0.01  130  86  7  37  6.8 (-2.9, 16)  0.11 12  9  0  3 
MEF25-75 (% pred)  0.5 (-3, 5)  0.23  130  65  15  50  0.0 (-10, 2.5)  1.25 4  2  1  1 
Oxygen-saturation (%)  1 (0, 1)  <0.01  143 66  45  32  Not  given           
Weight (kg)  1.0 (0.2, 1.6)  <0.01  131  106  6  19  1.2 (0.3, 2.1)  <0.01  60 52  1  7 
BMI (kg/m2)  0.4 (0.1, 0.7)  <0.01  114 92  6  16  Not  given           
 
 
Fig. (1). Medians and interquartile range of FEV1, FVC, oxygen-saturation and body weight during the seasons 2000/2001, 2001/2002, 
2002/2003 and 2003/2004 of the Israel rehabilitation programs. Additional measurements at the end of the first week (on average on day 9.2) 
of the 3-week stay were performed prospectively to determine when potential effects of the intervention become evident. The paired data 
from the 3 time points were compared by Friedman-ANOVA, followed by Dunn`s multiple comparison test. 
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Fig. (2). Spearman correlations between the duration of the 
rehabilitation programs in Germany/Switzerland and the changes in 
weight and lung function (FEV1). The Israel groups were not 
included as their stay was always fixed to 3 weeks. 
DISCUSSION 
  The overall completeness of the reports on quantitative 
key outcomes was clearly low in all rehabilitation programs 
investigated. Based on the data retrieved, both the Israel and 
the German/Swiss rehabilitation programs significantly 
improved overall lung function and weight of patients with 
cystic fibrosis of all age groups. At the Israel site FVC and 
oxygen-saturation improved, whereas at the German sites 
FEV1 did. While lung function improved early on and then 
remained stable, the gain of body weight was sustained and 
proportional to the length of the stay. Inter-individual 
responses were much more pronounced than variability 
within subjects. There were no differences in the extent of 
the rehabilitation effects at Israel and German/Swiss sites, as 
shown by matched comparisons. 
  This is to our knowledge the largest systematic analysis 
of rehabilitation programs in patients with cystic fibrosis 
published so far. One of the strengths of this study is that it 
included all patients of a predefined group of subjects from 
our centre that participated in the mentioned rehabilitation 
activities. Thus a selection bias was avoided and with the 
“intention to treat analysis” approach, we were able to obtain 
a “real life” assessment of the outcome. Since complete and 
unbiased up-to-date evaluation by the rehabilitation program 
providers are not published in an accessible way, we decided 
to do this analysis from the perspective of a site submitting 
patients, accepting potential disadvantages of this approach.  
 
 
Fig. (3). Changes of lung function and weight during rehabilitation 
in a matched group of patients of the Israel and German/Swiss 
rehabilitation program. The subjects from the German/Swiss sites 
were carefully matched by age, Pseudomonas state, sex, and 
baseline values of weight and lung function to fitting partners from 
the Israel site. Dotted lines connect matched subjects. Note that 
these are different subjects matched by chance and not the same 
individuals staying at both sites. Differences were assessed by 
Wilcoxon-Test and p values are indicated. 
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First, the submitting centre did not always receive the 
appropriate medicinal and psychosocial information 
necessary to judge on the success or failure for a particular 
patient, including missing data for key variables before and 
after the program, reports on exacerbations during a stay, 
data on other untoward events or on psychosocial problems. 
Second, the precise nature and frequency of interventions 
performed by the patients often remained unclear. We can 
only infer from the procedures stated in the program 
description provided by the rehabilitation centres what might 
be offered to the patient. Third, the results we present here, 
only concern cystic fibrosis patients from our centre and 
results of patients from other submitting sites are unknown. 
However, the major advantage of this approach is an 
overview on the outcome of the current rehabilitation 
programs currently utilized in Germany, Switzerland and 
Israel. Extra attention was put on the quality of the reports 
received from the rehabilitation sites, because values on key 
measurements often were missing in these reports. 
  The study clearly demonstrated that one of the 
apprehensions made before the study was true, i.e. that the 
quality of many of the reports received from the 
rehabilitation sites was inappropriate; clearly it cannot be 
tolerated that in up to more than 50% of the critical 
variables, e.g. lung function, describing the impact of an 
individual rehabilitation, are not given in the reports of some 
rehabilitation sites. We interpret this result as one strength of 
this study to clearly visualize missing data for the first time 
in a study on rehabilitation programs in cystic fibrosis, 
although of course the missing data somewhat weaken the 
value of the nevertheless large data set. For the future 
therefore it will be essential to improve data reporting on the 
part of rehabilitation sites. 
  Having these limitations in mind, some inferences can be 
drawn from this retrospective analysis. We show for two key 
indicators of health in cystic fibrosis patients, both, lung 
function and weight, an overall significant improvement by 
these rehabilitation programs. We determined the extent and 
variability of changes that can be expected and also the 
fraction of subjects not responding favorably. Of interest 
there was a steady time dependent improvement in body 
weight, which was demonstrated independently in two 
cohorts. Weight is an indicator not only of overall fitness but 
also an independent risk factor for survival in cystic fibrosis 
patients [15] similarly as FEV1 [16]. Due to the nature of our 
study and mainly because of the large amount of missing 
data reported, we also cannot analyze which intervention(s) 
were performed in which individual patients and which were 
responsible for the changes observed. Overall the results 
clearly demonstrate that rehabilitation programs as assessed 
here may objectively be helpful in a substantial fraction of 
cystic fibrosis patients and that they have the potential to be 
further developed into high quality and evidence based 
programs, which must be warranted by prospective 
evaluation. 
  Previous small cohort studies have already assessed the 
physiological impact of rehabilitation on nutritional status 
[17] and, at the Israeli site, on exercise capacity, which 
improved [10], and on pulmonary function and weight gain 
during and up to 3 months after the three week rehabilitation 
[18]. The results were in concordance with our findings. 
Unfortunately the latter study also had a retrospective design 
and the completeness of the sample is not known. Problems 
with selection bias must also be considered in the study on 
the impact of the rehabilitation program on quality of life 
indices [11]. In that study an unknown number of patients 
participating in rehabilitation programs at various sites over 
undetermined time periods were combined. Interestingly, the 
quality of life improved for a sustained period of at least two 
months after the end of the intervention [11]. A study of the 
site in Davos, Switzerland, which was also included in our 
study, reporting on 13 Israeli patients with cystic fibrosis, 
did not find improvement of lung function; however exercise 
tolerance and weight improved significantly [12]. The 
authors of the latter study argued for a reinstitution of 
rehabilitation activities for patients with cystic fibrosis, if 
special care is taken to prevent cross-infection. 
  The hygiene aspect is the key for any future development 
of up-to-date rehabilitation programs in cystic fibrosis. Our 
study did not target this issue. We did not systematically 
investigate our patients directly before and after a stay; 
however patients were only sent to those rehabilitation sites 
who were sensitized for the hygiene issue as demonstrated 
by cohorting all their patients on a time and space basis 
according to their microbiological status and enforcing 
hygiene rules in personal contact and inhalation equipment 
(see Table 1). As changes in the microbiological status of a 
patient were barely included in the reports from the 
rehabilitation sites, we could not assess this outcome. 
Although we believe that it is the responsibility of the 
rehabilitation site to demonstrate lack of transmission, we 
have recently started to also closely monitor our patients 
before and after rehabilitation, but in the future evaluation of 
respiratory pathogens by clonality is required to really assess 
the cross-infection risk. In the so called summer camps, 
where patients were encouraged to have close psychosocial 
contacts and where no structural measures for hygiene were 
implemented or controlled [3-6], but also in rehabilitation 
programs when the appropriate measures were not 
undertaken to prevent clonal spread of cystic fibrosis 
bacteria [19, 20], person to person transmission of bacteria 
have been demonstrated. Therefore unequivocally the 
rehabilitation sites have to demonstrate that they are safe 
from a hygiene aspect. Small cohorts have suggested if the 
appropriate hygienic precautions are introduced, transmiss-
ion can be prevented [9, 21]. In particular, lack of 
transmission has recently been demonstrated for older 
cohorts at the Israel site [9]. 
CONCLUSION 
  In patients with many severe chronic pulmonary diseases 
other than cystic fibrosis, rehabilitation programs in the 
Western world have successfully improved key outcome 
variables including lung function, exercise performance and 
health-related quality of life [1]. From our study and in 
agreement with other studies mentioned, we can conclude 
that such goals might also be achieved for patients with 
cystic fibrosis. If the rehabilitation programs are run for 
patients with cystic fibrosis at a maximum level of hygienic 
precautions to prevent cross-infections [22], together with 
individual improvements of health, the overall health care 
costs might be reduced. However, it is necessary in the short 
term, to improve the quality of the reports received from the 8    The Open Respiratory Medicine Journal, 2010, Volume 4  Griese et al. 
rehabilitation sites and to receive non-biased and 
standardized assessments of acknowledged outcomes from 
all subjects. This will help to identify patients who do not 
profit from the program and target efforts to specifically 
address their needs. In the long term and with the correct 
designs implemented it will either be possible to demonstrate 
safety and efficacy of the programs, or to conclude that this 
goal cannot be achieved by current programs which must 
then be stopped and replaced by improved rehabilitation 
efforts for cystic fibrosis patients. All this is the principal 
responsibility of the rehabilitation sites. On the one hand the 
support coming from the insurance companies who pay for 
the programs is appreciated; on the other hand, these 
companies should be encouraged to help to further improve 
the standards to be set for a successful rehabilitation. 
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